Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXD2P5
|
||||
| Drug Name |
N-{(S)-1-[2-(4-Benzyloxy-phenylamino)-ethylcarbamoyl]-3-methyl-butyl}-4-ethyl-benzamide
|
||||
| Synonyms |
CHEMBL59817
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C30H37N3O3
|
||||
| Canonical SMILES |
CCc1ccc(cc1)C(=O)N[C@@H](CC(C)C)C(=O)NCCNc2ccc(OCc3ccccc3)cc2
|
||||
| InChI |
InChI=1S/C30H37N3O3/c1-4-23-10-12-25(13-11-23)29(34)33-28(20-22(2)3)30(35)32-19-18-31-26-14-16-27(17-15-26)36-21-24-8-6-5-7-9-24/h5-17,22,28,31H,4,18-21H2,1-3H3,(H,32,35)(H,33,34)/t28-/m0/s1
|
||||
| InChIKey |
WALQYOULPGRLLM-NDEPHWFRSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.